echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > Large-scale mergers and acquisitions and strategic cooperation, Thermo fly into the instrument industry "aircraft carrier"

    Large-scale mergers and acquisitions and strategic cooperation, Thermo fly into the instrument industry "aircraft carrier"

    • Last Update: 2022-06-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    [ Star Enterprise of Chemical Machinery and Equipment Network ] As far as readers with a global vision and vision know, Thermo Fisher Scientific is the "aircraft carrier" leading enterprise in the instrument industry.

    Chemical machinery and equipment network star enterprise chemical machinery and equipment
    In 2019, the Thermo Fisher Group's operating income reached 25.
    54 billion U.
    dollars, and its net profit was 3.
    696 billion U.
    As of September 10, 2020, the total market value of the group company is as high as 165.
    5 billion US dollars, ranking in the forefront of instrument companies.


    Thermo Fisher has approximately 65,000 employees in 50 countries and regions.
    Products mainly include analytical instruments , laboratory equipment, reagents, consumables and software, etc.
    , providing comprehensive laboratory solutions to serve customers in all walks of life, covering the four major brands of hermo Scientific, Life Technologies, Fisher Scientific and Unity™ Lab Services series.

    Analytical Instruments
      Thermo Electron's predecessor was Thermo Electron, which was founded in 1956 with a venture capital of only 50,000 US dollars, and its initial product was a heat engine that converts heat energy into electrical energy.


      The thermoelectric company began to enter the instrument industry in the 1970s.
    At that time, the thermoelectric company had a keen insight into the wide range of requirements for environmental monitoring equipment , so the thermoelectric company established a department to develop air pollution monitoring equipment.
    In 1977, the thermoelectric company separated the department into the environmental instrument department, which also became the profitable business unit of the thermoelectric company at that time.

    Monitoring instrument
      How does Thermo Fisher take off from a small and micro enterprise with a mere US$50,000 to a prominent company in the instrument industry?

      Large-scale mergers and acquisitions: driving Thermo Fisher Scientific to advance at a high speed

      Thermo Fisher's ability to become a multinational instrument group with diversified business, technology and strength is closely related to its ability to use high-frequency and large-scale mergers and acquisitions.


      According to incomplete statistics, Thermo Scientific has made more than 70 mergers and acquisitions one after another.


      Thermo Fisher's more eye-catching mergers and acquisitions in the industry mainly include the following classic cases:

      In 2006, the thermoelectric company did not hesitate to spend a huge sum of 10.
    6 billion U.
    dollars to make a large-scale merger and acquisition of Fisher Scientific.
    The two companies formally merged, and the thermoelectric company was renamed Thermo Fisher Scientific (Thermo Fisher Scientific).
    At that time, the annual revenue of thermal power was only US$2.
    63 billion, while the annual revenue of Fisher was as high as US$5.
    58 billion.
    The Thermo Fisher M&A drama began.


      In 2010, Thermo Fisher did not stop the pace of mergers and acquisitions after spending US$2.
    1 billion on the acquisition of Diane.
    In the same year, it acquired Lomb Scientific.


      In 2012, Thermo Fisher invested US$925 million to acquire One Lambda, a supplier of blood test systems.


      In 2014, Thermo Fisher once again revealed the "weapon" of huge acquisitions, and acquired the * biotechnology company Life Technologies with a huge amount of US$13.
    6 billion.


      In 2016, Thermo Fisher launched four mergers and acquisitions.
    From *chip company Affymetrix, to real-time X-ray diffraction provider INEL, and even electron microscope company FEI, to stem cell company MTI-GlobalStem.
    Among them, Affymetrix, as a gene chip industry*, developed the world's first gene chip as early as 1989.
    Affymetrix's GeneChip biochip detection system is *a chip system approved by the European Union and the US FDA for in vitro diagnosis.


      In 2017, Thermo Fisher Scientific completed the merger and acquisition: it acquired Patheon, a Dutch pharmaceutical manufacturer, for US$7.
    2 billion; at the same time, it acquired FEI, a manufacturer of electron microscopes.


      At the beginning of 2018, Thermo Fisher successfully completed the acquisition of IntegenX, a fast DNA platform provider.


      In May 2019, it acquired Brammer Bio, a leading company in the field of gene and cell therapy viral vector manufacturing, with approximately US$1.
    7 billion in cash.


      On March 3, 2020, Thermo Fisher Scientific acquired the German* molecular diagnostics developer QIAGEN for a large sum of US$11.
    5 billion.
    The acquisition is a large-scale medical industry merger that has been announced so far this year.


      By continuously acquiring companies with technological advantages, Thermo Fisher Scientific has expanded and improved the industrial chain and made rapid advances on the road of instrument giants.
    Its revenue and market value are among the top in the instrument industry.


      Strategic cooperation: helping Thermo Fisher to accelerate its deployment in the Chinese market

      Thermo Fisher has placed the Chinese market in a very important strategic position.
    Thermo Fisher has developed strategic cooperation with local Chinese enterprises and institutions in food testing, genetic testing, technical support, laboratory construction, cell therapy, tumor diagnosis, and mass spectrometry.
    Accelerate the deployment of equipment and other fields, and continue to increase the market share of its products and services in the Chinese market.


      Thermo Fisher Scientific has entered China for more than 35 years.
    Its headquarters in China is in Shanghai, and branches have been established in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi’an, Nanjing, Wuhan, Kunming, etc.
    The number of employees More than 4,000; In order to meet the needs of the Chinese market, the existing 6 factories have set up 5 application development centers in Shanghai, Beijing and Suzhou at the same time to bring cutting-edge technologies and products to Chinese customers.


      In November 2017, Thermo Fisher Scientific and Beijing Municipal Commission of Science and Technology and Tsinghua University reached a consensus on strategic cooperation in the field of life sciences.
    The three parties will jointly build the Global Innovation Institute of Cryo-EM for Drug Discovery (CDD).


      On September 1, 2017, Thermo Fisher Scientific and Beijing Anzhen Hospital Medical Center Affiliated to Capital Medical University jointly established a joint laboratory and started a strategic cooperation.


      On January 31, 2018, Thermo Fisher and the Xiangyun County Comprehensive Inspection and Testing Institute of Yunnan Province signed a strategic cooperation agreement.
    The two parties will work together to build a modern and efficient testing laboratory.


      On May 2, 2018, Thermo Fisher Scientific and Xi'an Jiaotong University signed a strategic cooperation agreement.
    The two parties will carry out in-depth cooperation on the construction of school-level public platforms and professional laboratories in the Western Science and Technology Innovation Port of Xi’an Jiaotong University-Wisdom Learning Town (hereinafter referred to as "Innovation Port"), and jointly build the "Xi'an Jiaotong University-Thermo Fisher Scientific" Innovative Technology Joint Laboratory".


      On June 22, 2018, Thermo Fisher and Genuo Biosciences signed a strategic cooperation agreement.
    The two parties promised to jointly develop a new generation of tumor clinical detection products through a strong alliance and complementary advantages in the future.


      On October 22, 2018, Thermo Fisher Scientific and Wuhan University of Technology signed a strategic cooperation agreement.
    In this strategic cooperation, the two parties will establish a joint laboratory based on the Nano and Microstructure Research Center (NRC) of Wuhan University of Technology to further improve the productivity of scientific laboratories.


      On September 13, 2018, Thermo Fisher and Mecang Biosciences reached a strategic cooperation.
    The two parties promised to go hand in hand to jointly promote the localized production of clinical mass spectrometers and related supporting equipment, thereby accelerating the application and popularization of clinical mass spectrometry technology in China.


      On October 31, 2018, Thermo Fisher and Yunjian Medical formally signed a strategic cooperation agreement.
    The two parties will work together to build a modern and efficient testing laboratory, and the two parties will also cooperate in the joint development of testing methods and applications, and the training and development of testing talents.


      On November 27, 2018, Thermo Fisher and Beijing Hehe Diagnostics formally signed a strategic cooperation agreement.
    The two parties will cooperate in the field of laboratory operation and construction.


      On August 10, 2018, Thermo Fisher Scientific and Shanghai Tongshu Biotechnology Co.
    , Ltd.
    reached a strategic cooperation.
    The two parties will carry out in-depth cooperation in the field of tumor in vitro diagnostics, committed to the research and development of tumor companion diagnostic products, and accelerate the development of tumor genetic testing services.
    The implementation of China's clinical oncology market will better benefit cancer patients.


      According to incomplete statistics, in 2018 alone, Thermo Fisher reached 11 strategic cooperation agreements with local Chinese enterprises and institutions.


      At the same time, in May 2019, Thermo Fisher and Shanghai Jinsi Biotechnology Co.
    , Ltd.
    signed a strategic cooperation agreement.
    The two parties will jointly build a gene therapy joint base in Shanghai Zhangjiang Science City (Shanghai Medical Park), relying on Thermo Fisher's advantages in products, technologies, and integrated services in the field of cell and gene therapy, and jointly promote the industrialization and industrialization of gene therapy in China.
    Commercial development.


      With the successive launch of a series of strategic cooperation between Thermo Fisher Scientific and local Chinese enterprises and institutions, Thermo Fisher's "aircraft carrier" type head enterprise in the instrument industry has shown an increasingly accelerating pace in the Chinese market.


      Original title: Intensive mergers and acquisitions plus strategic cooperation, Thermo Fisher became the "aircraft carrier" in the instrument industry
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.